tiprankstipranks
Trending News
More News >
Tactile Systems Technology (TCMD)
NASDAQ:TCMD
US Market
Advertisement

Tactile Systems Technology (TCMD) Earnings Dates, Call Summary & Reports

Compare
409 Followers

Earnings Data

Report Date
Feb 24, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.44
Last Year’s EPS
0.4
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 03, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and strategic advancements in sales force expansion and product innovation. However, some challenges remain, including declines in certain channels and limited immediate impact from Medicare policy changes. Overall, the positive developments appear to outweigh the negative aspects.
Company Guidance
During the third quarter 2025 earnings call, Tactile Medical reported strong financial performance and raised its full-year revenue guidance, projecting total revenue in the range of $317 million to $321 million, representing 8% to 10% growth year-over-year. The company achieved total revenue of $85.8 million in Q3, marking a 17% increase compared to the previous year. Notably, lymphedema revenue grew by 11% year-over-year to $72.4 million, while airway clearance revenue surged by 71% to $13.4 million. Gross margins improved by 80 basis points to 76%, and adjusted EBITDA rose by 34% to $14.4 million. Tactile Medical's strategic initiatives, including expanding its sales force to 329 representatives and leveraging CRM technology, were highlighted as key drivers of this growth. The company also emphasized advances in clinical evidence and product innovation, particularly with its AffloVest product, which is nearing a market-leading position. Additionally, the company announced a new share repurchase program of up to $25 million, reflecting confidence in its business trajectory.
Strong Revenue Growth
Total revenue in Q3 2025 was $85.8 million, representing a 17% growth year-over-year. Lymphedema revenue increased 11% to $72.4 million, and airway clearance revenue surged 71% to $13.4 million.
Gross Margin and EBITDA Increase
Gross margins increased by 80 basis points to 76%, and adjusted EBITDA rose 34% year-over-year to $14.4 million.
Guidance Raised
Full year 2025 revenue guidance is increased to $317 million to $321 million, representing growth of 8% to 10% year-over-year.
Increase in Sales Force
The total sales force expanded to 329 reps, a 25% increase in headcount, enhancing the company's ability to meet demand in strategic markets.
Innovative Product Developments
Submission of a 510(k) for next-generation AffloVest with enhancements like reduced weight and digital connectivity.
Clinical Evidence Advancements
Successful long-term data from a head and neck lymphedema RCT demonstrated the effectiveness of Flexitouch Plus, supporting future reimbursement and coverage.

Tactile Systems Technology (TCMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TCMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 24, 2026
2025 (Q4)
0.44 / -
0.4
Nov 03, 2025
2025 (Q3)
0.17 / 0.36
0.2171.43% (+0.15)
Aug 04, 2025
2025 (Q2)
0.11 / 0.14
0.18-22.22% (-0.04)
May 05, 2025
2025 (Q1)
-0.08 / -0.13
-0.05-160.00% (-0.08)
Feb 18, 2025
2024 (Q4)
0.32 / 0.40
0.385.26% (+0.02)
Nov 04, 2024
2024 (Q3)
0.18 / 0.21
0.853-75.38% (-0.64)
Aug 05, 2024
2024 (Q2)
0.14 / 0.18
0.049267.35% (+0.13)
May 06, 2024
2024 (Q1)
-0.08 / -0.05
-0.033-51.52% (-0.02)
Feb 20, 2024
2023 (Q4)
0.21 / 0.38
0.29230.14% (+0.09)
Nov 06, 2023
2023 (Q3)
0.03 / 0.85
0.096788.54% (+0.76)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TCMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 03, 2025
$15.77$22.18+40.65%
Aug 04, 2025
$9.89$12.54+26.79%
May 05, 2025
$13.94$9.90-28.98%
Feb 18, 2025
$17.86$15.49-13.27%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Tactile Systems Technology (TCMD) report earnings?
Tactile Systems Technology (TCMD) is schdueled to report earning on Feb 24, 2026, After Close (Confirmed).
    What is Tactile Systems Technology (TCMD) earnings time?
    Tactile Systems Technology (TCMD) earnings time is at Feb 24, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TCMD EPS forecast?
          TCMD EPS forecast for the fiscal quarter 2025 (Q4) is 0.44.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis